Aromatase Inhibitors Current Events | Aromatase Inhibitors News | 2
|
| Page
2 of
17 |
325 Results |
|
|
|
Sort By:
Page Views | Date |
Newly appreciated membrane estrogen receptor important therapeutic target for breast cancer
New research at Rhode Island Hospital has uncovered the biological effects of a novel membrane estrogen receptor, a finding that has potential implications for hormonal therapy for breast cancer. view more (2009-07-02)
Regular use of selective COX-2 inhibitors decreases risk of breast cancer
Regular use of selective COX-2 inhibitors significantly reduces the risk of breast cancer. view more (2006-01-30)
New arthritis drugs less likely to cause side effects
A new group of arthritis drugs recommended by NICE for patients at risk of gastrointestinal complications may be safer than traditional drugs, research in this week's BMJ suggests. Claims that the drugs, known as selective COX2 inhibitors, caused fewer gastrointestinal problems than traditional arthritis drugs led to an increase in their use, but... view more... (2002-09-18)
Aspirin Does Not Reduce Effectiveness Of ACE Inhibitors
A systematic review in this week's issue of THE LANCET provides clarification for the debate about the use of angiotensin-converting-enzyme (ACE) inhibitors in combination with aspirin for the treatment of cardiovascular disease-combination therapy does not reduce the effect of ACE inhibition. Previous research has suggested that ACE inhibitors... view more... (2002-10-02)
Drugs may not delay onset of dementia; and more
Researchers have examined the evidence in favour of giving people considered to be close to developing dementia the drugs that are most commonly used to treat the condition itself. view more (2007-11-27)
Combination therapy reduces tumor resistance to radiation
Radiation is used to treat a variety of tumors and the response of tumors to radiation is dependent on endothelial cell death, which in turn limits oxygen delivery to the tumor, causing hypoxia and tumor cell death. view more (2007-06-08)
Experiments point to new treatments for PKD
A family of small molecules called CFTR inhibitors show promising effects in slowing the progression of polycystic kidney disease (PKD), the most common genetic disease of the kidneys, according to preliminary research reported in the July 2008 issue of the Journal of the American Society Nephrology. view more (2008-04-03)
Safety claims of new arthritis drugs may be misleading
Popular arthritis drugs, known as selective COX 2 inhibitors, may not be superior to traditional non-steroidal anti-inflammatory drugs, conclude researchers in this week’s BMJ. view more (2002-05-28)
A new approach to study flu drug resistance
Researchers have created a new approach for studying resistance to Neuraminidase Inhibitors (NI) in influenza. view more (2007-12-07)
New evidence eases some concerns about bone fracture risk with breast cancer drug
Copenhagen, Denmark: New evidence about the breast cancer drug anastrozole (Arimidex) shows that the incidence of a major side-effect - bone fractures - appears to stabilise after reaching a peak at two years of treatment, easing some of the concerns about the drug. This finding is the latest to come from evidence provided by the world's largest... view more... (2003-09-21)
ACE inhibitors may reduce death, heart attack and stroke in patients with coronary artery disease
ngiotension-converting enzyme (ACE) inhibitors, medications commonly used to treat hypertension (high blood pressure), may reduce cardiovascular risk and the risk of death in patients with coronary artery disease. view more (2006-04-11)
'Vioxx like' drugs may still be best option for arthritis, write scientists
Scientists believe that despite the current concerns around anti-inflammatory drugs like Vioxx, they may still be the best option for treating some forms of arthritis. view more (2006-01-19)
New Weapon for Fighting Antibiotic Drug Resistance
The most important antibiotics in general use today are the b-lactam family of products, but the medical community faces a serious problem with these antibiotics: the increasing development of drug resistance. The resistance is caused by hydrolysis of the b-lactam by a bacterial lactamase enzyme, but fortunately it can often be overcome by the use... view more... (2003-08-11)
PET scan can non invasively measure early assessment of treatment for common type of breast cancer
Non-invasive imaging can measure how well patients with the most common form of breast cancer - estrogen receptor positive type - respond to standard aromatase inhibitor therapy after only two weeks and shows similar findings that more invasive needle sampling identifies, according to a poster presentation to be presented at the ASCO annual... view more... (2009-05-27)
Benefits Of Anti-Clotting Drug Class For People With Acute Coronary Syndromes - But For Men Only? (p 189)
Results of a meta-analysis in this week's issue of THE LANCET lend further support to the benefits of the anti-clotting drugs glycoprotein IIb/IIIa inhibitors for the treatment of patients with acute coronary syndromes. However, an unexpected finding of the study suggests that men might be more likely to benefit from therapy with this class of... view more... (2002-01-17)
Opiates and cannaboids: the fight against pain
Opiates and cannaboids, apart from being drugs, have curative properties. Thus, opiates (morphine, methadone, etc.) have been used for some time as a pain-reducer and many cannaboids have also analgesic properties. Regarding their curative aspects, it is very important to know the effects produced after a prolonged period of treatment. Carrying... view more... (2003-03-18)
Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression
A new immunosuppression regimen for heart transplant patients can improve kidney function and prevent transplant coronary artery disease, according to two new Mayo Clinic studies. view more (2007-04-26)
Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression
A new immunosuppression regimen for heart transplant patients can improve kidney function and prevent transplant coronary artery disease, according to two new Mayo Clinic studies. view more (2007-04-27)
Researchers resolve how COX inhibitors cause heart hazards, and offer alternative treatment strategy
Inhibitors of cyclooxygenase-2 (COX-2) were developed to relieve inflammatory pain as effectively as nonsteroidal anti-inflammatory drugs (NSAIDS), but without one of their major side effects, gastrointestinal bleeding. view more (2006-04-14)
Mutation database helps personalized treatment of lung cancer
A groundbreaking free tool to help oncologists choose the best therapies for patients with non-small-cell lung cancer has been launched this week by scientists at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in... view more... (2008-04-25)
|
|
| Page
2 of
17 |
325 Results |
|
|
|
Sort By:
Page Views | Date |
|
